MHRA approves Bylvay for progressive familial intrahepatic cholestasis – Albireo Pharma
Albireo Pharma announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorization for Bylvay (odevixibat) for the treatment of all types of progressive… read more.